Tag: COVID-19

ACS: Effect of COVID-19 on surgical experience of residents, early-career surgeons

Editor's Note An American College of Surgeons survey finds a significant impact of the COVID-19 pandemic on surgical residents and early-career surgeons. Of 1,160 respondents (465 residents, 695 early-career surgeons), 96% reported the pandemic had a negative effect on their clinical experience. About one third reported inadequate access to personal…

Read More

By: Judy Mathias
October 19, 2020
Share

FDA reissues EUA for N95 respirators manufactured in China

Editor's Note The Food and Drug Administration (FDA) on October 15 announced that it reissued the Emergency Use Authorization (EUA) for certain N95 and other filtering face-piece respirators that are manufactured in China and are not approved by the Centers for Disease Control and Prevention’s National Institute for Occupational Safety…

Read More

By: Judy Mathias
October 19, 2020
Share

CDC: 85% of COVID-19 patients report ‘always’ or ‘often’ wearing masks

Editor's Note Recently published data from a study by the Centers for Disease Control and Prevention (CDC) finds that 70.6% of COVID-19-positive patients report “always” wearing a mask, 14.4% report “often” wearing a mask, and 3.9% report “never” wearing a mask (See Table: Reported use of cloth face covering or…

Read More

By: Judy Mathias
October 15, 2020
Share

Joint Commission: Lab surveyors to evaluate CMS reporting requirements for COVID-19 testing results

Editor's Note The Joint Commission announced October 14 that, effective October 15, surveyors will evaluate the Centers for Medicare and Medicaid Services (CMS) reporting requirements for COVID-19 testing results in the Laboratory Accreditation Program. Surveyors will review documentation of COVID-19 test result reporting during the Regulatory Review session of an…

Read More

By: Judy Mathias
October 15, 2020
Share

Study finds lasting protection in patients who have recovered from COVID-19

Editor's Note This study led by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that patients who survive serious COVID-19 infections have a long-lasting immune response against the virus. The study includes a cohort of case patients with known COVID-19 infection (343) and controls (1,548). Blood…

Read More

By: Judy Mathias
October 15, 2020
Share

Joint Commission issues new Quick Safety on telehealth

Editor's Note The Joint Commission on October 7 issued a new Quick Safety that focuses on the use of telehealth to deliver patient care while preventing exposure to COVID-19. Other benefits of telehealth in the Quick Safety include: promoting social distancing monitoring the progression of home-quarantined COVID-19 patients enabling providers…

Read More

By: Judy Mathias
October 15, 2020
Share

Increased unemployment linked to increased pediatric hospitalizations

Editor's Note This study by researchers from Children’s Mercy Hospital, Kansas City, Missouri, and others found that for four economy-sensitive conditions, increased unemployment was associated with increased pediatric hospitalizations. A 1% increase in unemployment was associated with a: 5% increase in hospitalization for substance abuse 4% increase for diabetes 2%…

Read More

By: Judy Mathias
October 13, 2020
Share

WHO warns against COVID-19 lockdowns

Editor's Note David Nabarro, MD, the World Health Organization’s (WHO’s) special envoy on COVID-19 in a video interview on October 10 urged world leaders to stop using lockdowns as their primary COVID-19 control method. He added that WHO believes the only time a lockdown is justified is to buy time…

Read More

By: Judy Mathias
October 13, 2020
Share

Study: Remdesivir vs placebo for COVID-19 treatment

Editor's Note In this double-blind, randomized, placebo-controlled study of IV remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection, remdesivir was found to be superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to either remdesivir (541) or placebo (521). Remdesivir…

Read More

By: Judy Mathias
October 13, 2020
Share

CMS halts COVID-19 testing in non-CLIA-certified labs

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification. The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19…

Read More

By: Judy Mathias
October 13, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat